<DOC>
	<DOCNO>NCT00615576</DOCNO>
	<brief_summary>This 4 6 week study look safety PK profile SB656933 healthy male smoker</brief_summary>
	<brief_title>Repeat Dose Study Male Healthy Volunteer Smokers</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Healthy adult male smoker 1865 year age normal genitourinary anatomy base physical examination . The subject normal colour Doppler epididymal ultrasound ( normal blood flow epididymal morphology ) screening . The first 10 mL urine void ( VB1 ) normal screen predose . Male subject must agree abstain use condom sexual intercourse pregnant female ; use condom/spermicide , addition female partner use another form contraception , IUD , diaphragm spermicide , oral contraceptive , injectable progesterone , subdermal implant tubal ligation , engage sexual intercourse female partner could become pregnant . This criterion must follow time first dose study medication 84 day last dose study medication . The subject QTc ( B ) &lt; 450msec screen prior dose Body weight = 50 kg ( 110 pound ) body mass index ( BMI ) 19 30 inclusive : BMI =weight kg/ ( height meter ) 2 Healthy male smoker must smoke 10 cigarette per day , least 2 month prior screen less 30 cigarette per day time enrolment . Subjects Forced Expiratory Volume ( FEV1 ) =80 % predict FEV1/Forced Vital Capacity ( FVC ) ratio=0.7 . Signed date write informed consent prior admission study The subject able understand comply protocol requirement , instruction protocolstated restriction . Any clinically relevant abnormality identify screen medical assessment , laboratory examination , 12lead ECG . The subject liver function test ( LFT ) elevate reference range prestudy screen remain elevated repeat LFT ( discuss sponsor , necessary ) . Subjects absolute neutrophil count ( ANC ) = 2.0x109/L . Subjects previously expose testicular radiotherapy . Subjects previous testicular prostate surgery include vasectomy . History prostatitis , epididymitis , epididymal cyst , structural abnormality testicular cancer . Subjects abnormalities renal tract , renal stone history Urinary Tract Infections ( UTI 's ) . Positive drug alcohol test screen prior dosing . Positive HIV , Hepatitis B surface antigen Hepatitis C antibody screen Use prescription nonprescription medication last 7 day 5 halflives ( whichever longer ) , particularly drug P450 CYP3A4 , CYP2B6 , CYP2C8 OATP1B1 substrates narrow therapeutic index , include vitamin herbal remedy St John 's Wort prior dose study medication . Consumption grapefruit grapefruit juice within seven day prior first dose study medication . Donation blood excess 500 mL within 56 day period prior dose . Exposure 3 new chemical entity within 12 month prior first dose day . Participation trial drug within 3 month start study participation trial new chemical entity within 4 month start study . Are receive treatment smoke cessation . Are use tobacco product cigarette ( e.g . pipe , cigar , snuff , chew tobacco ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Male ,</keyword>
	<keyword>Healthy Volunteer ,</keyword>
	<keyword>Smoker ,</keyword>
	<keyword>Cystic Fibrosis ,</keyword>
	<keyword>Chronic Obstructive Lung Disease</keyword>
</DOC>